Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives

Author(s): Lucija Kuna, Ivana Bozic, Tomislav Kizivat, Kristina Bojanic, Margareta Mrso, Edgar Kralj, Robert Smolic, George Y. Wu, Martina Smolic*.

Journal Name: Current Drug Metabolism

Volume 19 , Issue 10 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Drug-induced Liver Injury (DILI) is an important cause of acute liver failure cases in the United States, and remains a common cause of withdrawal of drugs in both preclinical and clinical phases.

Methods: A structured search of bibliographic databases – Web of Science Core Collection, Scopus and Medline for peer-reviewed articles on models of DILI was performed. The reference lists of relevant studies was prepared and a citation search for the included studies was carried out. In addition, the characteristics of screened studies were described.

Results: One hundred and six articles about the existing knowledge of appropriate models to study DILI in vitro and in vivo with special focus on hepatic cell models, variations of 3D co-cultures, animal models, databases and predictive modeling and translational biomarkers developed to understand the mechanisms and pathophysiology of DILI are described.

Conclusion: Besides descriptions of current applications of existing modeling systems, associated advantages and limitations of each modeling system and future directions for research development are discussed as well.

Keywords: Drug evaluation studies, preclinical, evidence-based toxicology, liver injury, drug-induced, side effects.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 19
ISSUE: 10
Year: 2018
Page: [830 - 838]
Pages: 9
DOI: 10.2174/1389200219666180523095355

Article Metrics

PDF: 47
HTML: 3